Eden Research had another poor trading year in 2020

By Stewart Dalby On 21 July last year (2020) we published an article which said, “Eden Research suffered a blip in its fortunes in 209 but expects better times in 2020”. According to Preliminary Results for the Year Ended 31 December 2020 released on 30 June 2021, however, Eden’s fortunes do not appear to have [...]

By |2021-09-04T08:01:21+00:00September 2nd, 2021|Eden Research Plc|Comments Off on Eden Research had another poor trading year in 2020

Eden Research was significantly negatively impacted by Covid-19 in 2020

Stewart Dalby On 21 July last year (2020) year we published an article which said, “Eden Research suffered a blip in its fortunes in 2019, but expects better times in the rest of 2020”. According to the Year-end trading update released on 11 February this year (2021), however, Eden’s fortunes do not appear to have [...]

By |2021-03-05T19:17:30+00:00March 4th, 2021|Eden Research Plc|Comments Off on Eden Research was significantly negatively impacted by Covid-19 in 2020

Eden Research turns out a crop of new products to restore lost revenue

By Stewart Dalby On 21 February this year we published an article which said, “Eden Research suffered a blip in its fortunes in 2019, but expects better times in the rest of 2020”. Simply put, Eden’s flagship product had a bad patch for a period in 2019. Following this blip the company started to put [...]

By |2020-07-11T14:04:53+00:00July 9th, 2020|Eden Research Plc|Comments Off on Eden Research turns out a crop of new products to restore lost revenue

Eden Research suffered a blip in its fortunes in 2019, but expects better times in the rest of 2020

Eden gets traction with Mevalone its agrochemical product that combats Botrytis a mould that causes diseases in grapes Eden Research describes itself as a company that provides natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries.   Eden was floated on London’s AIM in 2012. After spending a lot of [...]

By |2020-02-24T09:46:44+00:00February 20th, 2020|Eden Research Plc|Comments Off on Eden Research suffered a blip in its fortunes in 2019, but expects better times in the rest of 2020

Eden Research’s final results for the year ended 31 December 2018 confirm the company is moving closer to commerciality

We last wrote about Eden Research in January this year. We said that after a long, difficult period of little revenue and continued losses, the company seemed to be moving closer to commerciality. The final results for the year to 31 December 2019, released on 2 April 2019, appear to confirm that is the case. [...]

By |2019-05-17T18:00:52+00:00May 16th, 2019|Eden Research Plc|Comments Off on Eden Research’s final results for the year ended 31 December 2018 confirm the company is moving closer to commerciality

Eden Research’s trading update for 2018 suggests it is moving significantly closer to commercialism

Eden Research describes itself as a company that provides natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries. By the time Eden was floated on London’s AIM in 2012 the company had developed its first agrochemical product that was called 3AEY (now known as Melavone) which is a fungicide which targets [...]

By |2019-01-23T09:20:32+00:00January 22nd, 2019|Eden Research Plc|Comments Off on Eden Research’s trading update for 2018 suggests it is moving significantly closer to commercialism

Eden Research’s Half Yearly Report for 2017/18 indicates the company is moving significantly closer to commerciality

Eden Research describes itself as a company that provides breakthrough biopesticides and natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries. The company has developed its first agrochemical product that was called 3AEY (now known as Mevalone) which is a fungicide which targets botrytis, a mould that causes diseases in grapes. [...]

By |2018-10-25T09:10:40+00:00October 23rd, 2018|Eden Research Plc|Comments Off on Eden Research’s Half Yearly Report for 2017/18 indicates the company is moving significantly closer to commerciality

Eden Research delivers ‘a significant improvement in revenue’ in 2017

Eden Research describes itself as a company that provides breakthrough biopesticides and natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries. The company developed its first agrochemical product that was called 3AEY (now known as Mevalone) which is a fungicide which targets botrytis, a mould that causes diseases in grapes. Eden [...]

By |2018-03-29T19:30:41+00:00March 29th, 2018|Eden Research Plc|Comments Off on Eden Research delivers ‘a significant improvement in revenue’ in 2017

Eden Research’s broker says it is well placed to create value with its agrichemical product

We wrote about London AIM-listed Eden Research early in September when we reported that the company had had a hard time of it in 2016 and that its woes seemed to continue into 2017, with the result that its share price suffered a gradual decline. However, the group’s interim results for the six months ending [...]

By |2017-11-01T16:26:23+00:00November 1st, 2017|Eden Research Plc|Comments Off on Eden Research’s broker says it is well placed to create value with its agrichemical product

Eden Research’s broker says it is well placed to create value with its breakthrough fungicide for grapes

Shareholders in London AIM-listed Eden Research had a hard time of it in 2016 and for that matter the first half of 2017. The company was floated on AIM in 2014 and in 2015 reached a share price high of 25 pence. The shares collapsed towards the end of 2015. They are now 11.50p having [...]

By |2017-09-11T18:08:41+00:00September 11th, 2017|Eden Research Plc|Comments Off on Eden Research’s broker says it is well placed to create value with its breakthrough fungicide for grapes
Go to Top